PT - JOURNAL ARTICLE AU - Liu, Yupeng AU - Le, Siyu AU - Liu, Yi AU - Jiang, Huinan AU - Ruan, Binye AU - Huang, Yufeng AU - Ao, Xuemei AU - Shi, Xudong AU - Fu, Xiaoyi AU - Wang, Shuran TI - The effect of calcium supplementation in people under 35 years old: A systematic review and meta-analysis of randomized controlled trials AID - 10.1101/2022.04.14.22273724 DP - 2022 Jan 01 TA - medRxiv PG - 2022.04.14.22273724 4099 - http://medrxiv.org/content/early/2022/04/17/2022.04.14.22273724.short 4100 - http://medrxiv.org/content/early/2022/04/17/2022.04.14.22273724.full AB - Background and objective The effect of calcium supplementation on bone mineral accretion in people under 35 years old is inconclusive. To comprehensively summarize the evidence for the effect of calcium supplementation on bone mineral accretion in young populations (≤35 years).Design This is a systematic review and meta-analysis.Data sources The Pubmed, Embase, ProQuest and CENTRAL databases were systematically searched from database inception to April 25, 2021.Eligibility Randomized clinical trials assessing the effects of calcium supplementation on bone mineral density (BMD) or bone mineral content (BMC) in people under 35 years old.Results This systematic review and meta-analysis identified 43 studies involving 7382 subjects. Moderate certainty of evidence showed that calcium supplementation was associated with the accretion of BMD and BMC, especially on femoral neck (SMD 0.627, 95% CI 0.338 to 0.915; SMD 0.364, 95% CI 0.134 to 0.595; respectively) and total body (SMD 0.330, 95% CI 0.163 to 0.496; SMD 0.149, 95% CI 0.006 to 0.291), also with a slight improvement effect on lumbar spine BMC (SMD 0.163, 95% CI 0.008 to 0.317), no effects on total hip BMD and BMC and lumbar spine BMD were observed. Very interestingly, subgroup analyses suggested that the improvement of bone at femoral neck was more pronounced in the peri-PBM population (20-35 years) than the pre-PBM population (<20 years).Conclusion Our findings provided novel insights and evidence in calcium supplementation, which showed that calcium supplementation significantly improves bone mass, implying that preventive calcium supplementation before or around achieving PBM may be a shift in the window of intervention for osteoporosis.Funding This work was supported by Wenzhou Medical University grant [89219029].Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021251275 Funding StatementFunding This work was supported by Wenzhou Medical University grant [89219029]. The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data in this analysis are based on published studies. Supplementary data files contain all raw tabulated data are provided in appendix.